New appointment at Cadence Pharmaceuticals
This article was originally published in Scrip
Scott Byrd has joined Cadence Pharmaceuticals (US) as senior vice-president and chief commercial officer. He joins from Lilly, where he was most recently US brand leader for prasugrel. Before that, he was senior director of global brands, cardiovascular and acute care.